欧洲慢病毒载体市场,按组件(慢病毒启动子、慢病毒融合标签、慢病毒包装系统等)、类型(产品和服务)、代数(第 4 代、第 3 代、第 2 代和第 1 代)、工作流程(上游处理和下游处理)、递送方法(体内和体外)、疾病指征(癌症、遗传性疾病、传染病、兽医疾病等)、应用(基因治疗和疫苗学)、最终用户(生物技术公司、制药公司、合同研究组织、合同开发和制造组织 (CDMO) 和学术/研究机构)、国家(德国、法国、西班牙、意大利、荷兰、瑞士、俄罗斯、土耳其、欧洲其他地区)划分的行业趋势和预测到 2028 年
市场分析和见解:欧洲慢病毒载体市场
预计欧洲慢病毒载体市场将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析称,在 2021 年至 2028 年的预测期内,市场复合年增长率为 16.9%,预计到 2028 年将达到 3.2241 亿美元。分子生物学家经常使用病毒载体将遗传物质递送到细胞中。该过程可以在体内(生物体内)或细胞培养(体外)中进行。病毒已经开发出专门的分子机制来有效地将其基因组运输到它们感染的细胞内。慢病毒载体需求的不断增长和传染病的增加是预测期内推动市场需求的主要驱动因素。
慢病毒载体(LV) 是哺乳动物细胞中基因转移的有效载体,因为它们能够在非分裂细胞和分裂细胞中稳定表达目的基因。慢病毒是人类和动物病原体,已知其潜伏期长且感染持续。从初次感染到出现首批症状之间的时间可能长达数月或数年。分子生物学家经常使用病毒载体将遗传物质传递到细胞中。该过程可以在体内(活体生物体内)或细胞培养(体外)中进行。病毒已经开发出专门的分子机制,可有效地将其基因组运送到它们感染的细胞内。转导是通过载体传递基因或其他遗传物质,感染的细胞被称为转导细胞。除了分子生物学研究外,慢病毒载体还用于基因治疗和疫苗开发。主要市场参与者可提供各种产品和服务来生产慢病毒载体。
在此次 Covid-19 爆发期间,老年人口的增长和对疫苗开发的需求有效地促进了慢病毒载体市场的增长。然而,慢病毒载体缺乏可扩展性和下游纯化的局限性可能会阻碍慢病毒载体市场的未来增长。主要市场参与者的战略举措和基因组学资金的增加为欧洲慢病毒载体市场的增长提供了机遇。与慢病毒载体产品相关的严格监管政策和副作用对未来的市场增长构成了挑战。
欧洲慢病毒载体市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息,分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和市场情况,请联系我们获取分析师简报,我们的团队将帮助您创建收入影响解决方案,以实现您的预期目标。
欧洲慢病毒载体市场范围和市场规模
欧洲慢病毒载体市场根据成分、类型、生成、工作流程、交付方法、疾病指征、应用和最终用户分为八个显著的细分市场。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略,并确定您的核心应用领域和目标市场的差异。
- 根据成分,欧洲慢病毒载体市场细分为慢病毒启动子、慢病毒融合标签、慢病毒包装系统等。由于技术进步不断提高,预计 2021 年慢病毒包装系统部分将主导慢病毒载体市场。
- 根据类型,欧洲慢病毒载体市场分为产品和服务。由于欧洲政府加大对基因治疗的投资,预计 2021 年产品领域将主导慢病毒载体市场。
- 根据代数,欧洲慢病毒载体市场分为第 4 代、第 3 代、第 2 代和第 1 代。2021 年,第 4 代有望在慢病毒载体市场占据主导地位,因为它的诱变性和相关副作用较少。
- 根据工作流程,欧洲慢病毒载体市场分为上游加工和下游加工。由于基因治疗领域的研究机构和活动不断增加,预计 2021 年上游加工领域将主导慢病毒载体市场。
- 根据递送方式,欧洲慢病毒载体市场分为体内和体外。2021 年,由于体内研究贡献和疫苗生产的加速,体内部分预计将在慢病毒载体市场中占据主导地位。
- 根据疾病适应症,欧洲慢病毒载体市场细分为癌症、遗传性疾病、传染病、兽医疾病和其他疾病。由于欧洲各地区癌症病例发病率上升,预计 2021 年癌症领域将主导慢病毒载体市场。
- 根据应用,欧洲慢病毒载体市场分为基因治疗和疫苗学。2021 年,基因治疗领域预计将在慢病毒载体市场占据主导地位,因为其应用范围广泛,可为慢性病提供永久治愈。
- 根据最终用户,欧洲慢病毒载体市场分为生物技术公司、制药公司、合同研究组织、合同开发和制造组织 (CDMO) 和学术/研究机构。2021 年,由于越来越多的新研究机构成立用于研发应用,预计学术/研究机构将主导慢病毒载体市场。
欧洲慢病毒载体市场国家级分析
对欧洲慢病毒载体市场进行了分析,并按组成部分、类型、代数、工作流程、递送方式、疾病指征、应用和最终用户提供了市场规模信息。
欧洲慢病毒载体市场报告涵盖的国家包括英国、德国、法国、意大利、西班牙、俄罗斯、土耳其、荷兰、瑞士和欧洲其他国家。
由于制药行业对慢病毒载体的积极投入,德国成为欧洲地区发展最快的国家,并因此成为欧洲地区占主导地位的国家。
报告的国家部分还提供了影响单个市场因素和国内市场法规变化,这些变化影响了市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外,在提供国家数据的预测分析时,还考虑了欧洲品牌的存在和可用性以及由于来自本地和国内品牌的激烈或稀少的竞争而面临的挑战、销售渠道的影响。
主要市场参与者加大对慢病毒载体生产的战略举措,为慢病毒载体市场创造新机遇
欧洲慢病毒载体市场还为您提供每个国家特定市场增长的详细市场分析。此外,它还提供有关市场参与者战略及其地理分布的详细信息。数据适用于 2010 年至 2019 年的历史时期。
竞争格局和欧洲慢病毒载体市场份额分析
欧洲慢病毒载体市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对慢病毒载体市场的关注有关。
在欧洲慢病毒载体市场开展业务的主要公司包括 Applied Biological Materials Inc.、Creative Biolabs、bluebird bio, Inc.、System Biosciences, LLC、Cobra Biologics Limited、FUJIFILM Diosynth Biotechnologies(FUJIFILM Holdings Corporation 的子公司)、Sirion-Biotech GmbH、Merck KGaA、FinVector Oy、Oxford Biomedica、OriGene Technologies, Inc.、Sino Biological Inc.、Batavia Biosciences BV、Lonza、Takara Bio Inc.、Thermo Fisher Scientific Inc. 和 Cytiva(Danaher 的子公司)等。
全球各地的公司也签订了许多合同和协议,这也加速了慢病毒载体市场的发展。
例如,
- 2020 年 9 月,Waisman Biomanufacturing 与总部位于加州的生物科技公司 GigaGen 建立了战略合作伙伴关系,以开发一种治疗和预防 COVID-19 的新药。该公司建立的这一战略合作伙伴关系将增加 Waisman Biomanufacturing 对新型药物的开发和测试的使用,从而提高市场对其服务的认识。
- 2021 年 4 月,Oxford Biomedica 与勃林格殷格翰签署了一份新的为期三年的开发和供应协议,用于制造和供应病毒载体。预计该协议将在未来几年内促进该公司的销售增长。
市场参与者的合作、产品发布、业务扩展、奖励和认可、合资企业等策略正在增强公司在慢病毒载体市场的影响力,这也为组织的利润增长带来了好处。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
- introduction
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION
- OVERVIEW of EUROPE lentiviral vector market
- LIMITATIONs
- MARKETS COVERED
- MARKET SEGMENTATION
- MARKETS COVERED
- geographical scope
- years considered for the study
- currency and pricing
- DBMR TRIPOD DATA VALIDATION MODEL
- MULTIVARIATE MODELLING
- component LIFELINE CURVE
- primary interviews with key opinion leaders
- DBMR MARKET POSITION GRID
- vendor share analysis
- MARKET application COVERAGE GRID
- secondary sourcEs
- assumptions
- EXECUTIVE SUMMARY
- premium insiGHTS
- Adherent and Suspension cultures: OVERVIEW
- Pricing of Lentiviral Vectors: Product and Service
- Product
- Services
- Europe lentiviral vector market: regulatORY FRAMEWORK
- REGULATION IN THE UNITED STATES
- REGULATIONS IN EUROPE
- REGULATIONS IN INDIA
- REGULATIONS IN JAPAN
- Market Overview
- drivers
- RisE IN demand for viral vectors
- Emergence of COVID-19 and demand for vaccine development
- Benefits of Viral vectors for gene therapy
- RISE IN NUMBER OF INFECTIOUS DISEASES
- GROWING GERIATRIC POPULATION
- Restraints
- lack of scalability
- Limitations of downstream purification
- SHORTAGE OF SKILLED PERSONNELS
- OPPORTUNITIES
- Increased healthcare facility and funding for genomics
- RISE IN technological advancement
- IncreasE IN demand FOR personalized medicines
- Strategic Initiatives by Key market players
- CHALLENGEs
- stringent government approval policies
- Side-effects associated with lentiviral vectors integration
- IMPACT OF COVID-19 ON THE Europe Lentiviral vector Market
- impact on price
- impact on demand
- IMPACT ON SUPPLY CHAIN
- STRATEGIC DECISIONS of Government and MANUFACTURERS
- CONCLUSION
- Europe lentiviral vecTor market, By COMPONENT
- overview
- lentivirus packaging systems
- lentiviral promoter
- lentivirus promoter vectors
- lentivirus pROMOTERLESS VECTORS
- lentiviral fusion tags
- otherS
- Europe lentiviral vector market, By type
- overview
- product
- Human immunodeficiency virus (hiv)
- FELINE immunodeficiency virus (Fiv)
- EQUINE INFECTIOUS ANEMIA virus (eiav)
- services
- Europe lentiviral vector market, By GENERATION
- overview
- 4th generation
- 3rd generation
- 2nd generation
- 1st generation
- Europe lentiviral vector market, By workflow
- overview
- upstream processing
- vector amplification & expansion
- vector recovery/ harvesting
- downstream processing
- purification
- fill-finish
- Europe lentiviral vector market, By delivery method
- overview
- in-vivo
- ex-vivo
- Europe lentiviral vector market, By disease indication
- overview
- cancer
- genetic disorders
- b-thalessemia
- x-linked adreno leukodystrophy
- metachromatic leukodystrophy
- wiskott-aldrich syndrome
- others
- infectious diseases
- HIV
- OTHERS
- veterinary diseases
- others
- Europe lentiviral vector market, By application
- overview
- gene therapy
- recombinant protein expression
- functional assays
- in vitro transcription
- protein characterization
- others
- vaccinology
- Europe lentiviral vector market, By end user
- overview
- academic/ research institutes
- pharmaceutical companies
- contract development and manufacturing organizations
- biotechnology companies
- contract research organizations
- EUROPE Lentiviral Vector MARKET, by REGION
- EUROPE
- U.K.
- Germany
- France
- Italy
- Spain
- Netherlands
- Switzerland
- Russia
- Turkey
- Rest of Europe
- Europe Lentiviral Vector Market: COMPANY landscape
- company share analysis: Europe
- swot
- company profile
- Oxford Biomedica
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Thermo Fisher Scientific Inc.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Merck KGaA
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- LONZA
- COMPANY SNAPSHOT
- RECENT ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Cytiva (A Subsidiary of Danaher)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Applied Biological Materials Inc.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Batavia Biosciences B.V.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- bluebird bio, Inc.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- CELL BIOLABS, INC.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Creative Biolabs
- COMPANY SNAPSHOT
- SERVICE PORTFOLIO
- RECENT DEVELOPMENT
- COBRA BIOLOGICS LIMITED
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- FinVector Oy
- COMPANY SNAPSHOT
- SERVICE PORTFOLIO
- RECENT DEVELOPMENT
- FUJIFIM DIOSYNTH BIOTECHNOLOGIES (A SUBSIDIARY OF FUJIFILM HOLDINGS CORPORATION)
- COMPANY SNAPSHOT
- RECENT ANALYSIS
- SERVICE PORTFOLIO
- RECENT DEVELOPMENTS
- GENEMEDI
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- ORIGENE TECHNOLOGIES, INC.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- SINO BIOLOGICAL, INC.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- SIRION-Biotech GmbH
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- SYSTEM BIOSCIENCES, LLC
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- TAKARA BIO INC.
- COMPANY SNAPSHOT
- RECENT ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Waisman Biomanufacturing
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- questionnaire
- related reports
表格列表
TABLE 1 Thermo Fisher Scientific
TABLE 2 The Regents of the University of Michigan
TABLE 3 Kerafast
TABLE 4 Applied Biological Materials Inc.
TABLE 5 Europe lentiviral vector market, By component, 2019-2028 (USD million)
TABLE 6 Europe lentiviRUS PACKAGING SYSTEMS IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)
TABLE 7 Europe lentiviRal promoter IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)
TABLE 8 Europe lentiviral promoter in Lentiviral vector Market, By component, 2019-2028 (USD million)
TABLE 9 Europe lentiviRal FUSION TAGS IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)
TABLE 10 Europe OTHERS IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)
TABLE 11 Europe lentiviral vector market, By TYPE, 2019-2028 (USD million)
TABLE 12 Europe PRODUCT IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)
TABLE 13 Europe product in lentiviral vector market, By TYPE, 2019-2028 (USD million)
TABLE 14 Europe SERVICES IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)
TABLE 15 Europe lentiviral vector market, By generation, 2019-2028 (USD million)
TABLE 16 Europe 4TH-GENERATION IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)
TABLE 17 Europe 3RD-GENERATION IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)
TABLE 18 Europe 2ND-GENERATION IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)
TABLE 19 Europe 1ST-GENERATION IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)
TABLE 20 Europe lentiviral vector market, By work flow, 2019-2028 (USD million)
TABLE 21 Europe UPSTREAM PROCESSING IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)
TABLE 22 Europe upstream processing in Lentiviral vector Market, By method, 2019-2028 (USD million)
TABLE 23 Europe DOWNSTREAM PROCESSING IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)
TABLE 24 Europe downstream processing in Lentiviral vector Market, By method, 2019-2028 (USD million)
TABLE 25 Europe lentiviral vector market, By delivery method, 2019-2028 (USD million)
TABLE 26 Europe IN-VIVO IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)
TABLE 27 Europe EX-VIVO IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)
TABLE 28 Europe lentiviral vector market, By disease indication, 2019-2028 (USD million)
TABLE 29 Europe CANCER IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)
TABLE 30 Europe GENETIC DISORDERS IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)
TABLE 31 Europe genetic disorders in Lentiviral vector Market, By disease, 2019-2028 (USD million)
TABLE 32 Europe INFECTIOUS DISEASES IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)
TABLE 33 Europe infectious diseases in Lentiviral vector Market, By disease, 2019-2028 (USD million)
TABLE 34 Europe VETERINARY DISEASES IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)
TABLE 35 Europe others IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)
TABLE 36 Europe lentiviral vector market, By application, 2019-2028 (USD million)
TABLE 37 Europe GENE THERAPY IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)
TABLE 38 Europe gene therapy in Lentiviral vector Market, By application, 2019-2028 (USD million)
TABLE 39 Europe VACCINOLOGY IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)
TABLE 40 Europe lentiviral vector market, By end user, 2019-2028 (USD million)
TABLE 41 Europe ACADEMIC/ RESEARCH INSTITUTES IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)
TABLE 42 Europe pharmaceutical companies IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)
TABLE 43 Europe CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)
TABLE 44 Europe BIOTECHNOLOGY COMPANIES IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)
TABLE 45 Europe CONTRACT RESEARCH ORGANIZATIONS IN LENTIVIRAL VECTOR MARKET, By REGION, 2019-2028 (USD million)
TABLE 46 EUROPE Lentiviral Vector Market, By COUNTRY, 2019-2028 (USD Million)
TABLE 47 Europe Lentiviral Vector Market, By Component, 2019-2028 (USD Million)
TABLE 48 Europe Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)
TABLE 49 Europe Lentiviral Vector Market, By Type, 2019-2028 (USD Million)
TABLE 50 Europe Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)
TABLE 51 Europe Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)
TABLE 52 Europe Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)
TABLE 53 Europe Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)
TABLE 54 Europe Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)
TABLE 55 Europe Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)
TABLE 56 Europe Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)
TABLE 57 Europe Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)
TABLE 58 Europe Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)
TABLE 59 Europe Lentiviral Vector Market, By Application, 2019-2028 (USD Million)
TABLE 60 Europe Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)
TABLE 61 Europe Lentiviral Vector Market, By End User, 2019-2028 (USD Million)
TABLE 62 U.K. Lentiviral Vector Market, By Component, 2019-2028 (USD Million)
TABLE 63 U.K. Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)
TABLE 64 U.K. Lentiviral Vector Market, By Type, 2019-2028 (USD Million)
TABLE 65 U.K. Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)
TABLE 66 U.K. Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)
TABLE 67 U.K. Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)
TABLE 68 U.K. Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)
TABLE 69 U.K. Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)
TABLE 70 U.K. Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)
TABLE 71 U.K. Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)
TABLE 72 U.K. Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)
TABLE 73 U.K. Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)
TABLE 74 U.K. Lentiviral Vector Market, By Application, 2019-2028 (USD Million)
TABLE 75 U.K. Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)
TABLE 76 U.K. Lentiviral Vector Market, By End User, 2019-2028 (USD Million)
TABLE 77 Germany Lentiviral Vector Market, By Component, 2019-2028 (USD Million)
TABLE 78 Germany Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)
TABLE 79 Germany Lentiviral Vector Market, By Type, 2019-2028 (USD Million)
TABLE 80 Germany Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)
TABLE 81 Germany Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)
TABLE 82 Germany Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)
TABLE 83 Germany Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)
TABLE 84 Germany Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)
TABLE 85 Germany Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)
TABLE 86 Germany Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)
TABLE 87 Germany Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)
TABLE 88 Germany Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)
TABLE 89 Germany Lentiviral Vector Market, By Application, 2019-2028 (USD Million)
TABLE 90 Germany Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)
TABLE 91 Germany Lentiviral Vector Market, By End User, 2019-2028 (USD Million)
TABLE 92 France Lentiviral Vector Market, By Component, 2019-2028 (USD Million)
TABLE 93 France Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)
TABLE 94 France Lentiviral Vector Market, By Type, 2019-2028 (USD Million)
TABLE 95 France Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)
TABLE 96 France Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)
TABLE 97 France Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)
TABLE 98 France Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)
TABLE 99 France Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)
TABLE 100 France Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)
TABLE 101 France Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)
TABLE 102 France Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)
TABLE 103 France Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)
TABLE 104 France Lentiviral Vector Market, By Application, 2019-2028 (USD Million)
TABLE 105 France Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)
TABLE 106 France Lentiviral Vector Market, By End User, 2019-2028 (USD Million)
TABLE 107 Italy Lentiviral Vector Market, By Component, 2019-2028 (USD Million)
TABLE 108 Italy Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)
TABLE 109 Italy Lentiviral Vector Market, By Type, 2019-2028 (USD Million)
TABLE 110 Italy Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)
TABLE 111 Italy Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)
TABLE 112 Italy Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)
TABLE 113 Italy Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)
TABLE 114 Italy Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)
TABLE 115 Italy Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)
TABLE 116 Italy Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)
TABLE 117 Italy Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)
TABLE 118 Italy Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)
TABLE 119 Italy Lentiviral Vector Market, By Application, 2019-2028 (USD Million)
TABLE 120 Italy Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)
TABLE 121 Italy Lentiviral Vector Market, By End User, 2019-2028 (USD Million)
TABLE 122 Spain Lentiviral Vector Market, By Component, 2019-2028 (USD Million)
TABLE 123 Spain Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)
TABLE 124 Spain Lentiviral Vector Market, By Type, 2019-2028 (USD Million)
TABLE 125 Spain Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)
TABLE 126 Spain Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)
TABLE 127 Spain Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)
TABLE 128 Spain Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)
TABLE 129 Spain Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)
TABLE 130 Spain Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)
TABLE 131 Spain Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)
TABLE 132 Spain Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)
TABLE 133 Spain Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)
TABLE 134 Spain Lentiviral Vector Market, By Application, 2019-2028 (USD Million)
TABLE 135 Spain Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)
TABLE 136 Spain Lentiviral Vector Market, By End User, 2019-2028 (USD Million)
TABLE 137 Netherlands Lentiviral Vector Market, By Component, 2019-2028 (USD Million)
TABLE 138 Netherlands Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)
TABLE 139 Netherlands Lentiviral Vector Market, By Type, 2019-2028 (USD Million)
TABLE 140 Netherlands Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)
TABLE 141 Netherlands Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)
TABLE 142 Netherlands Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)
TABLE 143 Netherlands Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)
TABLE 144 Netherlands Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)
TABLE 145 Netherlands Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)
TABLE 146 Netherlands Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)
TABLE 147 Netherlands Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)
TABLE 148 Netherlands Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)
TABLE 149 Netherlands Lentiviral Vector Market, By Application, 2019-2028 (USD Million)
TABLE 150 Netherlands Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)
TABLE 151 Netherlands Lentiviral Vector Market, By End User, 2019-2028 (USD Million)
TABLE 152 Switzerland Lentiviral Vector Market, By Component, 2019-2028 (USD Million)
TABLE 153 Switzerland Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)
TABLE 154 Switzerland Lentiviral Vector Market, By Type, 2019-2028 (USD Million)
TABLE 155 Switzerland Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)
TABLE 156 Switzerland Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)
TABLE 157 Switzerland Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)
TABLE 158 Switzerland Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)
TABLE 159 Switzerland Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)
TABLE 160 Switzerland Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)
TABLE 161 Switzerland Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)
TABLE 162 Switzerland Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)
TABLE 163 Switzerland Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)
TABLE 164 Switzerland Lentiviral Vector Market, By Application, 2019-2028 (USD Million)
TABLE 165 Switzerland Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)
TABLE 166 Switzerland Lentiviral Vector Market, By End User, 2019-2028 (USD Million)
TABLE 167 Russia Lentiviral Vector Market, By Component, 2019-2028 (USD Million)
TABLE 168 Russia Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)
TABLE 169 Russia Lentiviral Vector Market, By Type, 2019-2028 (USD Million)
TABLE 170 Russia Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)
TABLE 171 Russia Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)
TABLE 172 Russia Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)
TABLE 173 Russia Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)
TABLE 174 Russia Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)
TABLE 175 Russia Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)
TABLE 176 Russia Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)
TABLE 177 Russia Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)
TABLE 178 Russia Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)
TABLE 179 Russia Lentiviral Vector Market, By Application, 2019-2028 (USD Million)
TABLE 180 Russia Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)
TABLE 181 Russia Lentiviral Vector Market, By End User, 2019-2028 (USD Million)
TABLE 182 TURKEY Lentiviral Vector Market, By Component, 2019-2028 (USD Million)
TABLE 183 TURKEY Lentiviral Promoter in Lentiviral Vector Market, By Component, 2019-2028 (USD Million)
TABLE 184 TURKEY Lentiviral Vector Market, By Type, 2019-2028 (USD Million)
TABLE 185 TURKEY Product in Lentiviral Vector Market, By Type, 2019-2028 (USD Million)
TABLE 186 TURKEY Lentiviral Vector Market, By Generation, 2019-2028 (USD Million)
TABLE 187 TURKEY Lentiviral Vector Market, By Workflow, 2019-2028 (USD Million)
TABLE 188 TURKEY Upstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)
TABLE 189 TURKEY Downstream Processing in Lentiviral Vector Market, By Method, 2019-2028 (USD Million)
TABLE 190 TURKEY Lentiviral Vector Market, By Delivery Method, 2019-2028 (USD Million)
TABLE 191 TURKEY Lentiviral Vector Market, By Disease Indication, 2019-2028 (USD Million)
TABLE 192 TURKEY Genetic Disorders in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)
TABLE 193 TURKEY Infectious Diseases in Lentiviral Vector Market, By Disease, 2019-2028 (USD Million)
TABLE 194 TURKEY Lentiviral Vector Market, By Application, 2019-2028 (USD Million)
TABLE 195 TURKEY Gene Therapy in Lentiviral Vector Market, By Application, 2019-2028 (USD Million)
TABLE 196 TURKEY Lentiviral Vector Market, By End User, 2019-2028 (USD Million)
TABLE 197 Rest of Europe Lentiviral Vector Market, By Component, 2019-2028 (USD Million)
图片列表
FIGURE 1 Europe LENTIVIRAL VECTOR MARKET: SEGMENTATION
FIGURE 2 EUROPE LENTIVIRAL VECTOR MARKET: DATA TRIANGULATION
FIGURE 3 Europe Lentiviral vector market: DROC ANALYSIS
FIGURE 4 Europe Lentiviral vector market: Europe VS REGIONAL MARKET ANALYSIS
FIGURE 5 Europe Lentiviral vector market: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE Lentiviral vector market: MULTIVARIATE MODELLING
FIGURE 7 EUROPE Lentiviral vector market: INTERVIEW DEMOGRAPHICS
FIGURE 8 EUROPE LENTIVIRAL VECTOR MARKET: DBMR MARKET POSITION GRID
FIGURE 9 EUROPE LENTIVIRAL VECTOR MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE lentiviral vector market: MARKET application COVERAGE GRID
FIGURE 11 Europe Lentiviral vector market: SEGMENTATION
FIGURE 12 growing geriatric population is expected to DRIVe THE Europe Lentiviral vector market IN THE FORECAST PERIOD OF 2021 to 2028
FIGURE 13 lentivirus packaging systems SEGMENT is expected to account for the largest share of the Europe LENTIVIRAL VECTOR MARKET in 2021 & 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGEs OF Europe lentiviral vector market
FIGURE 15 Europe lentiviral vector market: By component, 2020
FIGURE 16 Europe lentiviral vector market: By component, 2019-2028 (USD million)
FIGURE 17 Europe lentiviral vector market: By component, CAGR (2021-2028)
FIGURE 18 Europe lentiviral vector market: By component, LIFELINE CURVE
FIGURE 19 Europe lentiviral vector market: By TYPE, 2020
FIGURE 20 Europe lentiviral vector market: By TYPE, 2019-2028 (USD million)
FIGURE 21 Europe lentiviral vector market: By TYPE, CAGR (2021-2028)
FIGURE 22 Europe lentiviral vector market: By TYPE, LIFELINE CURVE
FIGURE 23 Europe lentiviral vector market: By generation, 2020
FIGURE 24 Europe lentiviral vector market: By generation, 2019-2028 (USD million)
FIGURE 25 Europe lentiviral vector market: By generation, CAGR (2021-2028)
FIGURE 26 Europe lentiviral vector market: By generation, LIFELINE CURVE
FIGURE 27 Europe lentiviral vector market: By work flow, 2020
FIGURE 28 Europe lentiviral vector market: By work flow, 2019-2028 (USD million)
FIGURE 29 Europe lentiviral vector market: By work flow, CAGR (2021-2028)
FIGURE 30 Europe lentiviral vector market: By work flow, LIFELINE CURVE
FIGURE 31 Europe lentiviral vector market: By delivery method, 2020
FIGURE 32 Europe lentiviral vector market: By delivery method, 2019-2028 (USD million)
FIGURE 33 Europe lentiviral vector market: By delivery method, CAGR (2021-2028)
FIGURE 34 Europe lentiviral vector market: By delivery method, LIFELINE CURVE
FIGURE 35 Europe lentiviral vector market: By disease indication, 2020
FIGURE 36 Europe lentiviral vector market: By disease indication, 2019-2028 (USD million)
FIGURE 37 Europe lentiviral vector market: By disease indication, CAGR (2021-2028)
FIGURE 38 Europe lentiviral vector market: By disease indication, LIFELINE CURVE
FIGURE 39 Europe lentiviral vector market: By application, 2020
FIGURE 40 Europe lentiviral vector market: By application, 2019-2028 (USD million)
FIGURE 41 Europe lentiviral vector market: By application, CAGR (2021-2028)
FIGURE 42 Europe lentiviral vector market: By application, LIFELINE CURVE
FIGURE 43 Europe lentiviral vector market: By end user, 2020
FIGURE 44 Europe lentiviral vector market: By end user, 2019-2028 (USD million)
FIGURE 45 Europe lentiviral vector market: By end user, CAGR (2021-2028)
FIGURE 46 Europe lentiviral vector market: By end user, LIFELINE CURVE
FIGURE 47 EUROPE Lentiviral Vector MARKET: SNAPSHOT (2020)
FIGURE 48 EUROPE Lentiviral Vector MARKET: BY COUNTRY (2020)
FIGURE 49 EUROPE Lentiviral Vector MARKET: BY COUNTRY (2021 & 2028)
FIGURE 50 EUROPE Lentiviral Vector MARKET: BY COUNTRY (2020 & 2028)
FIGURE 51 EUROPE Lentiviral Vector MARKET: BY COMPONENT (2021-2028)
FIGURE 52 Europe Lentiviral Vector Market: company share 2020 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.